Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹59 Cr.
Stock P/E
79
P/B
3.2
Current Price
₹158.1
Book Value
₹ 49.5
Face Value
10
52W High
₹283.2
52W Low
₹ 90
Dividend Yield
0%

Shree Pacetronix Overview

Business

Shree Pacetronix Ltd. is an Indian company operating in the Medical Equipment/Supplies/Accessories sector. Given its name "Pacetronix," it is highly probable that the company is involved in the manufacturing, distribution, and/or sale of medical electronic devices, possibly with a focus on cardiac care devices like pacemakers or related monitoring equipment, or a broader range of medical technology products. Its core business model would involve developing or sourcing medical devices, obtaining necessary regulatory approvals, and then selling these products to hospitals, clinics, healthcare providers, and potentially directly to patients or through a network of distributors. The company generates revenue through the sale of these medical devices and associated accessories or services.

Revenue Mix

Specific details regarding Shree Pacetronix Ltd.'s key business segments or revenue mix are not publicly available based on the provided information. However, within the Medical Equipment sector, potential segments could include diagnostic equipment, therapeutic devices (e.g., cardiac devices, surgical instruments), medical consumables, or services related to equipment installation and maintenance. Without further data, a precise breakdown is not possible.

Industry

The Indian medical equipment market is a rapidly growing industry, driven by increasing healthcare expenditure, a rising burden of chronic diseases, and improving healthcare infrastructure. The market is characterized by a mix of large multinational corporations (MNCs) and a growing number of domestic manufacturers. MNCs often dominate high-tech and specialized segments, while local players, like potentially Shree Pacetronix Ltd., often compete on factors like cost-effectiveness, regional distribution, and understanding of local market needs. The company's exact positioning would depend on its product portfolio (e.g., niche vs. broad), market share in specific product categories, and distribution network strength compared to both domestic and international peers.

MOAT

Without specific operational details, identifying a durable competitive advantage for Shree Pacetronix Ltd. is speculative. Potential moats in the medical equipment sector could include:

Regulatory Expertise: Strong ability to navigate India's complex regulatory landscape for medical devices.

Specialized Product Knowledge/Technology: Proprietary technology or deep expertise in a specific niche (e.g., pacemaker components).

Distribution Network: An established and efficient sales and service network across India.

Cost Efficiency: Ability to manufacture or source products at a lower cost than competitors, offering competitive pricing.

Brand Reputation: A trusted brand among healthcare professionals for reliability and quality.

Growth Drivers

Rising Healthcare Expenditure: Increasing public and private spending on healthcare in India.

Growing Disease Prevalence: An aging population and increasing incidence of non-communicable diseases (e.g., cardiovascular diseases) driving demand for medical devices.

Infrastructure Development: Expansion of hospitals, clinics, and diagnostic centers across urban and semi-urban areas.

Technological Advancement: Continuous innovation in medical technology creating new product opportunities and upgrading cycles.

Government Initiatives: "Make in India" campaigns and other policies promoting domestic manufacturing and affordable healthcare.

Risks

Intense Competition: Facing competition from both established global players and other domestic manufacturers.

Regulatory Changes: Evolving and stringent regulations for medical devices in India could impact product development, approval, and market access.

Technological Obsolescence: Rapid advancements in medical technology could render existing products outdated.

Pricing Pressure: Pressure from healthcare providers and government procurement policies to offer competitive pricing.

Supply Chain Disruptions: Dependence on raw materials or components which could be subject to global supply chain vulnerabilities.

Economic Downturns: Reduced healthcare spending by individuals and institutions during economic slowdowns.

Management & Ownership

Specific details about the promoters, key management personnel, or ownership structure of Shree Pacetronix Ltd. are not provided. In many Indian companies, a promoter group typically holds a significant stake and plays a crucial role in strategic decision-making. The quality of management would depend on their experience in the medical device sector, track record of innovation, regulatory compliance, and market execution.

Outlook

Shree Pacetronix Ltd. operates within an attractive and growing sector in India. The increasing demand for healthcare services and medical devices presents significant tailwinds for the company. Its ability to capitalize on these opportunities will depend on its product innovation, regulatory compliance, efficient manufacturing or sourcing, and robust distribution capabilities. The company will likely face ongoing challenges from intense competition, particularly from global players, and the need to adapt to evolving technological standards and regulatory frameworks. Success hinges on its strategic focus within the medical equipment landscape and its ability to carve out or expand its niche effectively.

Shree Pacetronix Share Price

Live · BSE · Inception: 1988
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Shree Pacetronix Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 7 5 4 4 4 5 7 4 5 5
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 5 4 4 4 5 7 4 5 5
Total Expenditure 4 4 4 3 3 4 5 4 4 4
Operating Profit 2 1 0 0 1 1 2 0 2 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 0 -0 1 1 2 0 1 1
Provision for Tax 1 0 0 -0 0 0 0 0 0 0
Profit After Tax 1 0 0 -0 0 1 1 0 1 1
Adjustments 0 0 0 -0 -0 0 -0 0 0 0
Profit After Adjustments 1 0 0 -0 0 1 1 0 1 1
Adjusted Earnings Per Share 4 1 0.1 -0.3 1.3 1.8 3.6 0.2 3 2

Shree Pacetronix Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 7 7 7 7 7 9 8 9 20 22 17 21
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 7 7 7 7 7 9 8 9 20 22 17 21
Total Expenditure 6 6 6 6 6 8 7 7 15 16 14 17
Operating Profit 1 1 1 1 1 1 1 2 6 6 2 5
Interest 0 0 0 0 0 0 0 0 0 0 1 0
Depreciation 1 1 1 0 0 1 1 0 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 -0 0 0 0 0 1 5 5 1 4
Provision for Tax -0 0 -0 0 0 0 0 0 1 1 0 0
Profit After Tax -0 -0 -0 0 0 0 0 1 3 3 1 3
Adjustments 0 0 0 -0 -0 0 0 -0 -0 0 0 0
Profit After Adjustments -0 -0 -0 0 0 0 0 1 3 3 1 3
Adjusted Earnings Per Share -0.2 -0.2 -0.9 0.4 0.4 0.7 0.1 2.2 9.1 9.3 2.1 8.8

Shree Pacetronix Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 5 5 5 5 5 6 6 6 10 13 14
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 1 1 1 1 1 1 0 1 0
Other Non-Current Liabilities 0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Total Current Liabilities 3 3 3 3 4 5 5 5 6 8 9
Total Liabilities 9 9 9 9 10 11 11 12 16 21 23
Fixed Assets 3 3 2 2 2 2 3 3 3 4 4
Other Non-Current Assets 0 0 1 1 2 2 2 2 2 2 2
Total Current Assets 6 6 6 6 7 6 6 7 11 15 17
Total Assets 9 9 9 9 10 11 11 12 16 21 23

Shree Pacetronix Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 1 0 1 1 1 0 0
Cash Flow from Operating Activities 0 1 0 1 0 2 1 2 2 -0 -0
Cash Flow from Investing Activities -0 -0 -1 -1 -1 -1 -1 -1 -1 -2 -0
Cash Flow from Financing Activities 0 -1 0 -1 0 -1 -0 -0 -1 2 0
Net Cash Inflow / Outflow 0 0 -0 0 -0 0 0 0 -1 0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 1 1 1 0 0 0

Shree Pacetronix Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.17 -0.24 -0.9 0.37 0.39 0.66 0.15 2.17 9.06 9.33 2.08
CEPS(Rs) 1.94 1.89 0.91 1.54 1.44 2.07 1.56 3.55 10.8 11.98 4.33
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 14.91 14.68 13.77 14.45 14.84 15.5 15.65 17.82 26.88 36.21 38.29
Core EBITDA Margin(%) 14.89 14.42 7.83 13.57 10.78 13.59 12.43 19.27 26.9 26.54 13.91
EBIT Margin(%) 4.37 4.32 -0.69 7.56 7.92 8.34 6.41 14.67 24.27 23.02 9.83
Pre Tax Margin(%) -1.77 -0.64 -6.45 2.79 3.49 4.03 1.74 11.49 22.81 20.97 6.21
PAT Margin (%) -0.87 -1.15 -4.68 1.95 1.94 2.71 0.7 8.46 16.09 15.24 4.46
Cash Profit Margin (%) 10.13 9.16 4.7 8.16 7.11 8.49 7.44 13.85 19.2 19.56 9.27
ROA(%) -0.67 -0.97 -3.79 1.48 1.43 2.23 0.49 6.9 23.18 17.89 3.42
ROE(%) -1.11 -1.61 -6.34 2.61 2.68 4.34 0.95 12.96 40.52 29.58 5.59
ROCE(%) 3.82 4.18 -0.64 6.51 6.63 8.05 5.46 14.81 46.13 34.76 9.13
Receivable days 85.62 77.05 104.03 129.34 143.39 130.66 150.75 123.63 71.58 77.58 122.59
Inventory Days 161.2 139.52 134.26 129.54 114.5 89.76 95.42 71.51 41.86 72.27 138.71
Payable days 48.16 25.87 30.02 37.91 40.73 43.87 58.67 29.31 20.22 21.44 36.89
PER(x) 0 0 0 0 32.77 0 78.44 9.38 10.78 16.27 29.91
Price/Book(x) 0 1.06 0.71 0 0.87 0 0.74 1.14 3.63 4.19 1.63
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.88 0.97 0.88 0.85 1.11 0.73 0.87 0.97 1.8 2.64 1.57
EV/Core EBITDA(x) 5.73 6.65 10.17 6.13 8.49 5.17 6.63 4.83 6.58 9.64 10.73
Net Sales Growth(%) -13.91 8.06 -6.71 -2.01 7.01 20.4 -13.76 22.11 119.44 8.81 -23.76
EBIT Growth(%) -63.15 7 -114.88 1174.35 12.06 26.82 -33.71 179.4 263.14 3.2 -67.43
PAT Growth(%) -126.22 -41.9 -279.77 140.79 6.68 67.98 -77.66 1373.43 317.47 3.02 -77.67
EPS Growth(%) -126.22 -41.83 -280.02 140.78 6.72 67.99 -77.62 1370.51 317.52 3.02 -77.67
Debt/Equity(x) 0.52 0.37 0.55 0.56 0.73 0.6 0.57 0.47 0.23 0.33 0.37
Current Ratio(x) 1.67 1.89 1.67 1.84 1.6 1.33 1.33 1.39 1.67 1.85 1.94
Quick Ratio(x) 0.76 1.06 0.9 1.16 1.03 0.91 0.91 1.07 1.21 1.15 1.15
Interest Cover(x) 0.71 0.87 -0.12 1.58 1.79 1.94 1.37 4.62 16.62 11.25 2.71
Total Debt/Mcap(x) 0 0.35 0.77 0 0.84 0 0.77 0.42 0.06 0.08 0.23

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -23% +24% +14% +9%
Operating Profit CAGR -67% 0% +15% +7%
PAT CAGR -67% 0% — —
Share Price CAGR -29% -25% +65% +31%
ROE Average +6% +25% +18% +8%
ROCE Average +9% +30% +22% +13%

Shree Pacetronix Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 36.44 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 63.56 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 24.2524.2524.2524.2524.2524.2524.2525.831.736.44
FII 0000000.140.1400
DII 0000000000
Public 75.7575.7575.7575.7575.7575.7575.6174.0668.363.56
Others 0000000000
Total 100100100100100100100100100100

Shree Pacetronix Peer Comparison

Medical Equipment/Supplies/Accessories Edit Columns

Shree Pacetronix Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Shree Pacetronix Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 36.44%.
  • Debtor days have increased from 21.44 to 36.89days.
  • Stock is trading at 3.2 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp